Equillium EQ 深 滬
等待開盤 11-26 09:30:00 美东时间
0.9344
-0.012
-1.29%
華盛通- 最 高0.995
- 今 開0.964
- 成交量 25.44万股
- 最 低 0.9301
- 昨 收 0.9466
- 總市值 5559.98万
- 52周最高 2.35
- 市盈率 靜 --
- 換手率 0.43%
- 52周最低 0.27
- 委 比 -80.77%
- 總股本 5950.32万
- 歷史最高 27.05
- 量 比 0.57
- 振 幅 6.86%
- 歷史最低 0.27
- 每 手 1
- 風險率 0.44%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Equillium to Participate in Upcoming Investor Conferences
Equillium, a clinical-stage biotech company focused on developing therapies for severe autoimmune and inflammatory disorders, announced that its management will participate in the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 11:30 AM EST, and the Evercore ISI 8th Annual Healthcare Conference on December 3, 2025, at 3:50 PM EST. Both events will feature fireside chats and one-on-one meetings. Investors can review the com...
11-20 21:35
AI Powerhouses Or Small-Cap Rebound? ETFs To Watch As Morgan Stanley Eyes S&P 500 At 7,800
Morgan Stanley's 7,800 S&P 500 call signals a two-speed rally. See the ETFs best placed for the AI mega-cap surge and small-cap rebound.
11-20 04:38
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
- Closed financing of up to $50 million; initial tranche of $30 million provides runway through 2027. - Hosted KOL event highlighting AhR's role in UC and potential of EQ504, a novel oral AhR modulator. - EQ504 Phase 1 clinical study initiation planned for mid-2026. - Third quarter 2025 financial results: Revenue of $0, R&D expenses of $1.3 million, G&A expenses of $3.3 million, net loss of $4.2 million, and cash of $33.1 million. - About EQ5...
11-13 21:05
Equillium to Participate in Upcoming Investor Conferences
Equillium Inc. announced that its management will participate in the Stifel Healthcare Conference on November 12, 2025, with a presentation and one-on-one meetings, and the Jefferies Global Healthcare Conference in London from November 18–20, 2025, focusing on one-on-one investor meetings. These events allow investors to engage with Equillium’s leadership, and a live webcast of the Stifel presentation will be available on the company’s Events & P...
11-04 13:30
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Equillium, Inc. announced that its Compensation Committee granted inducement awards of nonstatutory stock options to purchase 7,200 shares of common stock to a new employee under the 2024 Inducement Plan. The stock options, with an exercise price of $1.41 per share, will vest over four years, with 25% vesting after one year and the remainder monthly over the following 36 months. The company is developing EQ504, an aryl hydrocarbon receptor modula...
11-03 21:05
为无人驾驶而生！同力重工联合易控智驾全球首发分布式动力纯电无人矿卡EQ100E
2025年10月28日，第二十一届中国国际煤炭采矿技术交流及设备展览会在北京隆重开幕。同力重工携手易控智驾，在全球行业嘉宾见证下，正式发布分布式动力纯电无人驾驶...
10-28 17:36
EQ Resources Appoints New Company Secretary
The latest update is out from EQ Resources Limited ( ($AU:EQR) ). EQ Resources ...
10-28 14:28
